Approval · Notice of Compliance 17662 · 2016
RAMIPRIL: Notice of Compliance 17662
Issued January 5, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17662
- Date
- January 5, 2016
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreement beetween two companies
- Canadian reference product
- ALTACE (Hoechst Marion Roussel Canada Inc.)